The FDA has received 12,797 adverse event reports for dogs that name Lotilaner.
- 12,797 reports name Lotilaner in dogs, which is 1.3% of all 1,001,380 dog reports. A report counts under every active ingredient it names.
- 14% are marked serious and 2.7% record a death or euthanasia; across all dog reports those figures are 29% and 5.4%.
- 32% are complaints that the product did not work (38% across all dog reports).
- The clinical signs reported most are vomiting, diarrhoea and other abnormal test result.
- The FDA lists 1 approved animal drug application containing Lotilaner for dogs, the earliest approved in 2018.
- None of this is a rate. The FDA data does not record how many dogs were given Lotilaner, so it cannot say how often any of this happens.
How the reports break down
| What the reports say | Reports | Share of this medicine's reports | All dog reports |
|---|---|---|---|
| Marked seriousthe FDA record flags the report as serious | 1,783 | 14% | 29% |
| Death or euthanasiathe outcome recorded in the report, with no finding of cause | 344 | 2.7% | 5.4% |
| Did not worka complaint that the product failed to work, which the FDA files as an adverse event | 4,158 | 32% | 38% |
| Seizurea seizure or convulsion is among the clinical signs | 812 | 6.3% | 4.4% |
| Not used per labelthe report says the product was not used the way its label directs | 1,661 | 13% | 21% |
Where on the body do the reported signs sit?
Not on the body: Did not work 24% Whole body 8.8% How it was given 1.7%
- Stomach and gut45%vomiting, diarrhoea, not eating, emesis (multiple) and 4 more
- Did not work24%lack of efficacy (ectoparasite) - tick, lack of efficacy (bacteria) - borrelia, lack of efficacy (endoparasite) - heartworm, lack of efficacy (ectoparasite) - flea and 4 more
- Whole body8.8%lethargy, lethargy
- Brain and nerves8.5%seizure, ataxia, shaking
- Blood and organ tests6.0%other abnormal test result
- Behaviour3.7%behavioural disorder
- Skin and coat1.9%itching
- How it was given1.7%unpalatable
Each figure is a share of sign mentions among the 25 signs reported most for Lotilaner in dogs. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.
Clinical signs reported most
- Vomiting3,508 27%
- Diarrhoea1,736 14%
- Other abnormal test result929 7.3%
- Lack of efficacy (ectoparasite) - tick810 6.3%
- Lack of efficacy (bacteria) - Borrelia790 6.2%
- Seizure765 6.0%
- Lethargy747 5.8%
- Lethargy625 4.9%
Reports received per year
Is it approved for dogs?
The FDA lists 1 approved animal drug application containing Lotilaner for dogs, the earliest approved in 2018.
| Product | Form | Approved for | First approved | FDA application |
|---|---|---|---|---|
| CredelioElanco US Inc. | Chewable Tablets RX | Dog | 2018 | 141-494 |
What can you do next?
Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.
Where can you go from this result?
This result is one of 94 in the lookup. Open it in the lookup to set it beside another medicine, or read how the counts were collected.
- Trilostane in dogs11,925
- Maropitant in dogs11,886
- Deracoxib in dogs11,012
- Nitenpyram in dogs10,786
To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.
Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.